NASDAQ · Biotechnology

Pluri Inc. (PLUR) Stock

$0.95 -4.68% NASDAQ: PLUR Healthcare

Valuation

MetricValue
Price$0.95
Market Cap$10.28M
P/E Ratio-0.42
P/B Ratio-0.49
P/S Ratio11.04
EPS (TTM)$-3.56
52-Week High$4.87
52-Week Low$0.85
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE144.63%
ROA-98.26%
ROCE318.22%
Gross Margin-2300.00%
Operating Margin-2200.00%
Net Margin-24.25%
Debt/Equity-1.52
Current Ratio0.69

Annual Financials (USD)

Metric20222023202420252026
Revenue$0$0$0$1.0M$1.0M
Operating Profit$-42.0M$-27.0M$-22.0M$-22.0M$-25.0M
Net Profit$-41.0M$-28.0M$-21.0M$-23.0M$-24.0M
EPS$-10.24$-6.18$-3.99$-3.56$-2.44
Op Margin-17774.8%-9493.4%-6796.9%-1659.9%-2454.5%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$68.0M$51.0M$40.0M$39.0M$25.0M
Total Liabilities$36.0M$35.0M$34.0M$40.0M$42.0M
Cash$10.0M$5.0M$7.0M$6.0M$4.0M
Borrowings$29.0M$30.0M$30.0M$34.0M$35.0M

Latest News

Pluri Chairman Alejandro Weinstein’s Cumulative Investment Exceeds $17 Million, Ownership Surpasses 30% GlobeNewswire · Jul 14, 2026 Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing GlobeNewswire · Jun 2, 2026 Pluri Inc. (PLUR): One of the Premier Lab-Grown Meat Stocks to Invest In Insider Monkey · May 30, 2026 Pluri Insider Ups Holding During Year Simply Wall St. · May 28, 2026 Pluri: Fiscal Q3 Earnings Snapshot Associated Press · May 14, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$-37.0M$-23.0M$-18.0M$-18.0M$-20.0M
Investing Cash Flow$12.0M$9.0M$10.0M$6.0M$9.0M
Financing Cash Flow$10.0M$0$9.0M$0$0
Net Cash Flow$-20.0M$-5.0M$1.0M$0$-3.0M
Free Cash Flow$-37.0M$-23.0M$-18.0M$-20.0M$-20.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-1.77
FCF Yield-180.21%
Quick Ratio0.27
Interest Coverage-26.77
Return 1Y-65.07%
Return 3Y-70.83%
Return 5Y-93.86%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANTXAN2 Therapeutics, Inc. $4.40 -5.98% -5.24 $158.47M 0.00%
BOLDBoundless Bio, Inc. $2.53 -1.94% -0.92 $56.86M 0.00%
IBIOiBio, Inc. $0.87 -5.33% -3.46 $56.01M 0.00%
INTSIntensity Therapeutics, Inc. $3.63 -1.36% -0.71 $9.81M 0.00%
ITRMIterum Therapeutics plc $0.03 -10.98% -0.06 $1.60M 0.00%

About Pluri Inc.

Pluri Inc. is led by CEO Yaacov Yanay, employs 106 people, headquartered in IL, publicly traded since 2003.

Pluri Inc. (PLUR) stock trades at $0.95 with a market capitalization of $10.28M. The stock is valued at a price-to-earnings (P/E) ratio of -0.42, price-to-book of -0.49, price-to-sales of 11.04. Over the past 52 weeks the stock has ranged between $0.85 and $4.87, and currently trades 80.5% below its 52-week high.

On profitability, Pluri Inc. generates a return on equity (ROE) of 144.63% — well above the market average, a sign of a high-quality business, return on capital employed of 318.22%, an operating margin of -2200.00%, a net profit margin of -24.25%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides